Damian Marron, CEO, Txcell 00:00:00

Share On Facebook Share On Twitter

TxCell develops innovative, cost-effective, personalized T cell-based immunotherapies for severe chronic inflammatory diseases with high medical need and no treatment options.

Recent Videos